Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShort-Term Debt repayments
Ratios

Gain Therapeutics (GANX) Receivables - Other (2021 - 2025)

Gain Therapeutics (GANX) has 5 years of Receivables - Other data on record, last reported at $517094.0 in Q3 2025.

  • For Q3 2025, Receivables - Other changed N/A year-over-year to $517094.0; the TTM value through Sep 2025 reached $517094.0, changed N/A, while the annual FY2024 figure was $494684.0, N/A changed from the prior year.
  • Receivables - Other reached $517094.0 in Q3 2025 per GANX's latest filing, down from $1.1 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $1.1 million in Q2 2025 and bottomed at $33261.0 in Q1 2023.
  • Average Receivables - Other over 5 years is $324244.7, with a median of $98954.5 recorded in 2022.
  • Peak YoY movement for Receivables - Other: increased 6.8% in 2022, then tumbled 64.94% in 2023.
  • A 5-year view of Receivables - Other shows it stood at $81862.0 in 2021, then rose by 6.8% to $87430.0 in 2022, then plummeted by 61.96% to $33261.0 in 2023, then surged by 1387.28% to $494684.0 in 2024, then grew by 4.53% to $517094.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Receivables - Other were $517094.0 in Q3 2025, $1.1 million in Q2 2025, and $638961.0 in Q1 2025.